Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Harriette Van Spall , Faiez Zannad Added: 9 months ago
ESC Congress 2025 - Vericiguat did not reduce the risk of cardiovascular mortality and hospitalization in heart failure with reduced ejection fraction, fewer cardiovascular deaths and all-cause deaths were observed.Host, Dr Harriette Van Spall (McMaster University, CA) is joined on-site at ESC Congress 2025 in Madrid by Dr Faiez Zannad (University of Lorraine, FR) to discuss pivotal results from… View more
Author(s): Rui Baptista Added: 1 month ago
HFA Congress 2026 — Dr Rui Baptista (University of Coimbra, Coimbra, PT) joins us to discuss findings from the PORTHOS (PORTuguese Heart Failure Observational Study), a nationwide, population-based epidemiological study examining heart failure prevalence and characteristics in mainland Portugal using contemporary diagnostic tools.PORTHOS enrolled 6,189 adults aged 50 and above, randomly selected… View more
Author(s): Faiez Zannad , Harriette Van Spall Added: 1 month ago
In this episode of Masterclass, host, Dr Harriette Van Spall speaks with Professor Faiez Zannad about the challenge of making heart failure evidence more globally representative.Professor Zannad is an emeritus Professor of Therapeutics and Cardiology at the University of Lorraine in Nancy, France, and a leading clinical trialist in heart failure whose studies have informed international treatment… View more
Author(s): Javed Butler, Shelley Zieroth, Gianluigi Savarese Start date: Sep 04, 2024
This CME accredited roundtable is designed to equip healthcare professionals with the knowledge and tools necessary to identify high-risk patients indicative of worsening HF and to implement effective management strategies. Join Dr Javed Butler (Baylor Scott & White Health, Dallas, US); Dr Shelley Zieroth (University of Manitoba, Winnipeg, CA) and Prof Gianluigi Savarese (Karolinska Institute,… View more
Author(s): Felipe Martínez Added: 2 months ago
ACC.26 - In this expert interview filmed at ACC.26 in New Orleans, Prof. Felipe Martínez discusses how late-breaking heart failure data are reshaping contemporary pharmacological management. The conversation focuses on new spironolactone results, advanced hemodynamic strategies in HFpEF, and the expanding role of cardiometabolic therapies, including GLP‑1 receptor agonists, in optimising outcomes… View more